# Beta-blockade in Unruptured Intracranial Aneurysm

Study · id `cardio:ct-nct06249802` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06249802](<https://clinicaltrials.gov/study/NCT06249802>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06249802

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06249802. Randomized; quadruple masking; primary purpose prevention. Start 2025-01-01 (anticipated); primary completion 2029-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06249802, source copy `cardio:ctgov-nct06249802-2024-02-08`, retrieved 2026-11-18)
- Planned start: 2025-01-01 (anticipated) (ClinicalTrials.gov record NCT06249802, source copy `cardio:ctgov-nct06249802-2024-02-08`, retrieved 2026-11-18)
- Primary completion: 2029-01-01 (anticipated) (ClinicalTrials.gov record NCT06249802, source copy `cardio:ctgov-nct06249802-2024-02-08`, retrieved 2026-11-18)
- Completion: 2030-01-01 (anticipated) (ClinicalTrials.gov record NCT06249802, source copy `cardio:ctgov-nct06249802-2024-02-08`, retrieved 2026-11-18)
- Countries: Poland (ClinicalTrials.gov record NCT06249802, source copy `cardio:ctgov-nct06249802-2024-02-08`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06249802-2024-02-08`, retrieved 2026-11-18)

## The registry's words

- Brief title: Beta-blockade in Unruptured Intracranial Aneurysm
- Acronym: BBLURAN
- Condition: Intracranial Aneurysm
- Intervention (Drug): Nebivolol
- Intervention (Drug): Placebo
- Lead sponsor: Jagiellonian University
- Lead sponsor class: OTHER
- Collaborator: University Hospital in Krakow
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry intervention name matches this record: Nebivolol (`cardio:nebivolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Jagiellonian University (`cardio:org-jagiellonian-university`)

## Provenance

Content hash: 5444875cf5ccab2b83709d9e02629ca8a236fe0c98833449f8c43c28c2023d83
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
